Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Akebia Therapeutics (AKBA) Asset Utilization Ratio (2017 - 2025)

Akebia Therapeutics (AKBA) has disclosed Asset Utilization Ratio for 8 consecutive years, with 0.75 as the latest value for Q4 2024.

  • On a quarterly basis, Asset Utilization Ratio fell 8.29% to 0.75 in Q4 2024 year-over-year; TTM through Dec 2024 was 0.75, a 8.29% decrease, with the full-year FY2024 number at 0.69, up 6.4% from a year prior.
  • Asset Utilization Ratio was 0.75 for Q4 2024 at Akebia Therapeutics, down from 0.8 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.26 in Q1 2023 to a low of 0.06 in Q1 2020.
  • A 5-year average of 0.59 and a median of 0.46 in 2020 define the central range for Asset Utilization Ratio.
  • Biggest YoY gain for Asset Utilization Ratio was 2861.99% in 2020; the steepest drop was 71.59% in 2020.
  • Akebia Therapeutics' Asset Utilization Ratio stood at 0.38 in 2020, then dropped by 1.09% to 0.37 in 2021, then surged by 168.91% to 1.01 in 2022, then decreased by 18.83% to 0.82 in 2023, then dropped by 8.29% to 0.75 in 2024.
  • Per Business Quant, the three most recent readings for AKBA's Asset Utilization Ratio are 0.75 (Q4 2024), 0.8 (Q1 2024), and 0.82 (Q4 2023).